Skip to main content

ZYRTEC®

The #1 Allergist Recommended Brand Among OTC Oral Antihistamines

ZYRTEC® starts working fast at hour 1 and provides a full 24-hours of relief for your patients with mild to moderate indoor and outdoor allergy symptoms.

Use products only as directed.

Order ZYRTEC® samples for your patients

Kenvue recognizes the importance of supporting HCPs and the patients they treat. Start receiving ZYRTEC® samples for your practice now.

Leaders in advancing self care

Starts working in 1 hour1

Relieves itchy, watery eyes⁴

Delivered  33% greater relief vs Allegra at 21–24 hours³

Equip Your Patients with Management Tools!

The ZYRTEC® AllergyCast® app is a free tool that helps your patients manage their allergies effectively. By leveraging local data on pollen counts and air quality, it provides personalized daily allergy impact scores to predict symptom severity. Patients can receive tailored insights and access helpful tips and exclusive savings on ZYRTEC® products.

ZYRTEC® AllergyCast® app

Watch the Chronic Spontaneous Urticaria (CSU) Webinar

In this webinar, Dr. Friedman will discuss the diagnosis and classification of Chronic Spontaneous Urticaria, Dr. Gupta will address the disease burden and patient case, and Nurse Julia will focus on CSU management.

Zyrtec® Resources

*ZYRTEC® relieves sneezing; runny nose; itchy, watery eyes; and itching of the nose or throat.

 

†ZYRTEC® 10 mg starts working at hour 1 and Claritin® starts working at hour 3, based on first dose on the first day of a 2-day study in 2 pollen chamber studies. Primary endpoint measured mean improvement from baseline in Major Symptom Complex (MSC) severity score. MSC symptoms included runny nose, sniffles, itchy nose, nose blows, sneezes, and watery eyes.

 

‡Based on first dose on the first day of a 2-day pollen chamber study with ZYRTEC® 10 mg vs Allegra® 180 mg at hours 21 to 24. Primary efficacy endpoint was change in total symptom severity score from baseline at hours 21 to 24. Total Symptom Severity Complex score was defined as the sum of self-assessed severity scores of 4 symptoms: runny nose, sneezing, itchy nose/palate/throat, and itchy/watery eyes.

 

References: 1. Day JH, Briscoe M, Widlitz MD. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. J Allergy Clin Immunol. 1998;101(5):638-645. 2. Day JH, Briscoe M, Rafeiro E, Chapman D, Kramer B. Comparative onset of action and symptom relief with cetirizine, loratadine, or placebo in an environmental exposure unit in subjects with seasonal allergic rhinitis: confirmation of a test system. Ann Allergy Asthma Immunol. 2001;87(6):474-481. 3. Patel M, Urdaneta E, Franklin K, et al. Cetirizine significantly relieves ocular allergy symptoms in subjects with seasonal allergic rhinitis. Poster Abstract. Data on file, Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division. 4. Day JH, Briscoe MP, Rafeiro E, Hewlett D, Chapman D, Kramer B. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the environmental exposure unit: duration of effect in subjects with seasonal allergic rhinitis. Allergy Asthma Proc. 2004;25(1):59-68.